Literature DB >> 11545630

Body mass index and the incidence of visually significant age-related maculopathy in men.

D A Schaumberg1, W G Christen, S E Hankinson, R J Glynn.   

Abstract

BACKGROUND: Reports have suggested relationships of body weight with age-related maculopathy (ARM), particularly its nonneovascular (dry) forms, but results are inconsistent and prospective data are scarce.
OBJECTIVE: To examine prospectively relationships of body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters) with visually significant dry and neovascular ARM during an average of 14.5 years of follow-up.
METHODS: Incident ARM was assessed by medical record confirmation of self-reported ARM among the 21 121 men participating in the Physicians' Health Study who (1) were followed up for at least 7 years, (2) were free of visually significant ARM at baseline, and (3) had information on BMI and cigarette smoking. We used proportional hazards regression models to estimate rate ratios (RRs) and 95% confidence intervals (CIs) for visually significant dry ARM (256 cases) and neovascular ARM (84 cases) within 4 categories of BMI: lean (< 22.0), normal (22.0-24.9), overweight (25.0-29.9), and obese (> or = 30.0).
RESULTS: Adjusting for age, randomized aspirin and beta carotene assignments, and cigarette smoking, the incidence for visually significant dry ARM was lowest in men with a normal BMI. Compared with these men, the RRs (95% CIs) were as follows: 1.43 (1.01-2.04) for lean, 1.24 (0.93-1.66) for overweight, and 2.15 (1.35-3.45) for obese men. Although there was no significant relationship of BMI with the diagnosis of neovascular ARM, due to the small number of cases these analyses could not rule out an important relationship.
CONCLUSIONS: Obesity is a risk factor for visually significant ARM in men, in particular for dry ARM. However, the relationship of BMI with dry ARM appears to be J-shaped, and the leanest individuals also appear to be at increased risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545630      PMCID: PMC1634828          DOI: 10.1001/archopht.119.9.1259

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  35 in total

1.  A prospective study of alcohol consumption and the risk of age-related macular degeneration.

Authors:  U A Ajani; W G Christen; J E Manson; R J Glynn; D Schaumberg; J E Buring; C H Hennekens
Journal:  Ann Epidemiol       Date:  1999-04       Impact factor: 3.797

2.  MACULAR DISEASES: SENILE CHANGES OF THE CHORIOCAPILLARIS OF THE POSTERIOR POLE.

Authors:  E FRIEDMAN; T R SMITH
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1965 Jul-Aug

3.  Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

Authors:  W Smith; P Mitchell; S R Leeder; J J Wang
Journal:  Arch Ophthalmol       Date:  1998-05

4.  Body Mass Index at the age of 18 and its effects on 32-year-mortality from coronary heart disease and cancer. A nested case-control study among the entire 1932 Dutch male birth cohort.

Authors:  M D Hoffmans; D Kromhout; C D Coulander
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

5.  Overweight, underweight, and mortality. A prospective study of 48,287 men and women.

Authors:  J C Seidell; W M Verschuren; E M van Leer; D Kromhout
Journal:  Arch Intern Med       Date:  1996-05-13

6.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

7.  A prospective study of cigarette smoking and age-related macular degeneration in women.

Authors:  J M Seddon; W C Willett; F E Speizer; S E Hankinson
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

8.  The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; T Franke
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

9.  Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1992-12

10.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

Authors:  C H Hennekens; J E Buring; J E Manson; M Stampfer; B Rosner; N R Cook; C Belanger; F LaMotte; J M Gaziano; P M Ridker; W Willett; R Peto
Journal:  N Engl J Med       Date:  1996-05-02       Impact factor: 91.245

View more
  38 in total

1.  A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.

Authors:  Debra A Schaumberg; William G Christen; Piotr Kozlowski; David T Miller; Paul M Ridker; Robert Y L Zee
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

Review 2.  Age-related macular degeneration.

Authors:  Tariq Ayoub; Nishal Patel
Journal:  J R Soc Med       Date:  2009-02       Impact factor: 5.344

3.  Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.

Authors:  William G Christen; Debra A Schaumberg; Robert J Glynn; Julie E Buring
Journal:  Arch Ophthalmol       Date:  2011-03-14

Review 4.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 5.  Dry age-related macular degeneration: A currently unmet clinical need.

Authors:  Jean-François Girmens; José-Alain Sahel; Katia Marazova
Journal:  Intractable Rare Dis Res       Date:  2012-08

6.  Iris color and associated pathological ocular complications: a review of epidemiologic studies.

Authors:  Hong-Peng Sun; Yi Lin; Chen-Wei Pan
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

7.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

Authors:  Traci E Clemons; Roy C Milton; Ronald Klein; Johanna M Seddon; Frederick L Ferris
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

8.  Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

9.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

10.  Longitudinal incidence of adverse outcomes of age-related macular degeneration.

Authors:  Ashley Wysong; Paul P Lee; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.